Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contacts

medRxiv(2022)10.1101/2022.02.05.22270481Source: DataRank Database

Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contacts is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (29)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Agha Zeeshan Mirza ORCID,Nicholas Gallagher,Alec Boudreau,Lydia Garcia,Tong Yu ORCID

Live enrichment

PubMed:35169814 OpenAlex:https://openalex.org/W4210889272

National Institutes of Health

Grant: 3U54HL143541-02S2

Clinical Studies Core

National Institutes of Health

Grant: 5UM1AI068613-16

LC: HIV PREVENTION TRIALS NETWORK

National Institutes of Health

Grant: 1R61HL158541-01

A phase I trial of AdKCNH2-G628S gene therapy for post-op atrial fibrillation

National Institutes of Health

Grant: 2U54EB007958-11

Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases

National Institutes of Health

Grant: 5R01HL141434-02

FHS-NEXT - Framingham Novel EXam using Technology

National Institutes of Health

Grant: 5R01HL137734-04

Smartwatch Monitoring for Atrial Fibrillation After Stroke

National Institutes of Health

Grant: 5R01HL155343-05

SUPPORT-AF IV

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/02/07/2022.02.05.22270481.full.pdf

GREENhttps://doi.org/10.1101/2022.02.05.22270481

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/02/07/2022.02.05.22270481.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.02.05.22270481

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35169814

Fields of Study

SARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchInfection Control and VentilationMedicine0303 health sciences03 medical and health sciences

Keywords

AsymptomaticNatMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)AntigenInfectivityVirologySalivaPandemicInternal medicineImmunologyVirusDiseaseCOVID-19 TestingSARS-CoV-2610COVID-19Humanstest performancePandemicsSensitivity and Specificityrapid diagnostics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being